Systane Ultra eye drops by Alcon Inc. - lubricant care for dry eyes

Systane Ultra eye drops land in the palm as a small, translucent 10 ml bottle, the cool plastic pressing lightly against the fingertips before the first drop falls onto a dry, burning eye surface. Ophthalmologist Dr. Andrea Lischke describes the sensation as a "smooth, cooling film" that spreads quickly and eases discomfort. The product sits inside Alcon’s broader Systane portfolio as a core lubricant drop for everyday dry eye symptoms.

Formulation and key ingredients

Systane Ultra is formulated as a lubricant eye drop based on polyethylene glycol 400 and propylene glycol, two widely used polymer-based moisturizers for the tear film. Alcon combines these agents with the gelling polymer hydroxypropyl guar, which interacts with the ocular surface to create a more stable, longer-lasting protective layer over the cornea. In practice, this means users experience a thicker, more cohesive tear film compared with simple saline-based products.

The solution is preserved with Polyquad (polyquaternium-1), a quaternary ammonium preservative that Alcon positions as gentler to the ocular surface than traditional benzalkonium chloride, especially for chronic users. Systane Ultra is pH balanced close to the natural tear pH and isotonic to minimize stinging when the drop hits the eye. The formulation is designed for compatibility with most soft contact lenses, although professional guidance often recommends instilling the drop before lens insertion or after removal to maximize comfort.

Use, dosage and everyday handling

Alcon’s official instructions for Systane Ultra recommend one or two drops as needed in the affected eye, with frequency adjusted to symptom severity. Dry eye patients typically use the product several times per day, often in bursts during screen work or air-conditioned office hours. The lubricant is intended for temporary relief of burning, irritation and discomfort due to dry eye, environmental factors or reduced blink rate, rather than for acute infection or trauma.

In the hand, the bottle’s dropper tip delivers a precise, narrow stream; users feel a small cool bead forming, then releasing onto the lower fornix. Product manager Maria Schneider at Alcon’s German unit emphasizes consistent technique: wash hands, tilt head back, avoid touching the tip to the lash line, and close the eye gently after instillation for several seconds. This allows the hydroxypropyl guar-based matrix to spread uniformly and bind to the tear film.

Market positioning within Systane

Systane Ultra occupies the mid-range position in Alcon’s Systane hierarchy, between the basic Systane hydration drops and more intensive formats like Systane Gel, Systane Nighttime and Systane Complete. The Ultra variant is marketed primarily for moderate dry eye, including office workers, older adults and contact lens wearers with episodic discomfort. Pricing surveys from German pharmacies and online retailers place the 10 ml bottle roughly in the lower double-digit euro range, often around 10 to 15 EUR depending on retailer and discount campaigns.

Alcon’s Systane franchise is central to its dry eye strategy, complementing prescription therapies and surgical devices with an over-the-counter platform that generates recurring purchases. Industry analysts see lubricant eye drops like Systane Ultra as a steady, relatively low-volatility contributor to the company’s Vision Care segment revenues. In Europe, Alcon distributes Systane via pharmacy channels and online shops; in the United States, big-box retailers, grocery chains and e-commerce sites play a larger role.

Evidence and professional reception

Clinical and post-marketing data on Systane formulations show improvements in tear film stability and patient-reported comfort compared with simple artificial tears in selected dry eye cohorts. Studies published in peer-reviewed journals have evaluated Systane’s hydroxypropyl guar technology and reported extended protection times and better staining scores of the corneal surface. Dry eye specialists, such as Professor E. Müller at a university eye clinic, typically recommend starting with lubricating drops like Systane Ultra before escalating to prescription anti-inflammatory therapy.

The product is not positioned as a cure for dry eye disease but as a symptomatic management tool that can be combined with lifestyle changes such as regular blinking exercises, humidifiers and screen breaks. For patients with meibomian gland dysfunction or severe keratoconjunctivitis sicca, more lipid-heavy or gel-like drops and prescription options may be required. Nonetheless, Systane Ultra remains a widely suggested first-line OTC option in European and North American practice guidelines for mild to moderate cases.

Availability and regulatory status

Systane Ultra is registered as an over-the-counter medical device or drug product depending on jurisdiction, with national regulatory classifications differing between markets. In Germany, it is commonly sold as an over-the-counter eye drop in pharmacies and online, without the need for a prescription, provided patients follow the package leaflet and seek medical advice for persistent symptoms. The product is also available in similar packaging in other European Union countries, though local labeling languages and regulatory designations can vary.

In the United States, Systane Ultra is an OTC lubricant eye drop sold beside competitors from Bausch + Lomb and Allergan, with the 10 ml bottle and multi-pack formats appearing on shelves and digital marketplaces. Alcon’s Swiss headquarters coordinates global branding while regional units adapt messaging to local medical practice and language. Across markets, preservatives and bottle sizes may differ slightly, but the core lubricating concept of polyethylene glycol, propylene glycol and hydroxypropyl guar remains consistent.

Context and Alcon stock

For Alcon Inc., Systane Ultra is part of a growing dry eye care portfolio that also includes Systane Hydration, Systane Complete and nighttime gel formats, collectively forming a recurring revenue stream in the Vision Care segment. The Alcon Inc. share is listed on SIX Swiss Exchange under ISIN CH0432492467 and reflects, among other factors, the global uptake of Systane eye drops as a regular purchase in pharmacies and retail chains.